Safety and effectiveness of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease - A SEER-Medicare study
{{output}}
Introduction: Immune checkpoint inhibitors (ICIs) have transformed cancer treatment; however, their use in patients with pre-existing autoimmune diseases (PAD) remains controversial. This study evaluated the real-world safety and... ...
